View Older Stories
-
Citi hikes Eli Lilly & Co. (LLY) price target on Incretin estimates
-
Eli Lilly (LLY) PT Raised to $675 at Citi
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Better than feared Q2 results, worse than expected reactions
-
Today's most important downgrades
-
It's Good to Be Eli Lilly (LLY) in 2022 Says Citi Analyst
-
Lilly to Participate in Citi's 17th Annual BioPharma Conference
-
2 Reasons Why Citi Downgraded Merck (MRK) to Neutral Today, Opened a Negative Catalyst Watch
-
Pre-Open Stock Movers 09/29: (GREE) (AUVI) (LCID) Higher; (LFMD) (LSPD) (EQT) Lower (more...)
-
Eli Lilly (LLY) Stock Soars As Citi Upgrades to Buy Amid Recent Selloff in Shares
-
UPDATE: Citi Upgrades Eli Lilly (LLY) to Buy (correction)
-
Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities
-
Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities and Removal of the Note Caps for
-
Eli Lilly & Co. (LLY) Announces Cash Tender Offer for for Up to $1.5B of its Notes
-
Lilly Announces Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities
-
Lilly to Participate in Citi's 16th Annual BioPharma Virtual Conference
-
Eli Lilly lifts 2020 profit forecast; coronavirus fuels stockpiling of its medicines
-
Elanco Animal Health (ELAN) Announces Upsizing and Pricing of Common Stock and Pricing of Tangible Equity Unit Offerings
-
Elanco Animal Health Announces Upsizing and Pricing of Common Stock and Pricing of Tangible Equity Unit Offerings
-
Elanco Animal Health (ELAN) Announces Common Stock, Tangible Equity Unit Offerings Associated with Financing Acquisition of Bayer's Animal Health Business
-
Elanco Animal Health Announces Common Stock and Tangible Equity Unit Offerings Associated with Financing Acquisition of Bayer’s Animal Health Business
-
Lilly (LLY) Announces Agreement to Acquire Dermira (DERM) for $18.75/Share in $1.1 Billion Deal
-
Lilly Announces Agreement to Acquire Dermira
-
Lilly Announces the Pricing Terms of its Cash Tender Offer for Up to $2,000,006,000 Aggregate Principal Amount of Its Outstanding Debt Securities
-
Lilly Announces the Early Tender Results and Upsizing of Its Pending Cash Tender Offer to Up to $2,000,006,000 Aggregate Principal Amount of Its Outstanding Debt Securities
-
Lilly Announces Cash Tender Offer for Up to $2.0 Billion Aggregate Principal Amount of Its Outstanding Debt Securities
-
Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop
-
Elanco to become No.2 in animal health with $7.6 billion Bayer deal
-
Eli Lilly (LLY) PT Lowered to $120 at Citi
-
Eli Lilly (LLY) PT Raised to $124 at Citi
-
Exclusive: Activist investor Elliott has stake in Germany's Bayer - sources
-
UPDATE: Citi Downgrades Eli Lilly (LLY) to Neutral
-
Lilly's diabetes drug data impresses, hurts rival Novo's shares
-
Elanco Animal Health Incorporated Announces IPO Closing
-
Animal health firm Elanco surges 41 percent on debut
-
Elanco Animal Health (ELAN) IPO Opens 34% Higher
-
Elanco Announces Pricing of Initial Public Offering
-
Lilly's (LLY) Subsidiary Elanco Animal Health's (ELAN) IPO Prices at $24/Share
-
Elanco Announces Pricing of Initial Public Offering
-
Pre-Open Movers 10/10: (KALV) (ANAB) (VICL) Higher; (JBL) (LLY) (AXTA) Lower (more...)
-
Earnings, bank shares propel S&P 500 to record high
-
Eli Lilly (LLY) PT Lowered to $92 at Citi; 'Baricitinib FDA Rejection Painful but Broader Thesis Still Intact'
-
Pre-Open Movers 04/17: (CBLI) (ALR) (STRP) Higher; (OMED) (LNCE) (INCY) Lower (more...)
-
Citi Maintains Buy Rating and $100 PT on Eli Lilly (LLY) Following Mgmt Meetings with New CEO
-
Pre-Open Stock Movers 01/18: (CLCD) (SHLO) (JAZZ) Higher; (GIMO) (TGT) (CSX) Lower (more...)
-
Complete Donald Trump Stock Impact Guide
-
Wall St. ends up slightly as focus turns to earnings
-
Halvorsen's Viking Global Shows New Stakes in Aetna (AET), Amazon (AMZN), Fox (FOXA); Exits Lilly (LLY), Micron (MU), (more...)
-
Notable Analyst Rating Changes 6/25: (MRO) (LLY) (ODP) Upgraded; (ALE) (CHK) (NFLX) Downgraded
-
Notable Analyst Rating Changes 6/17: (WLL) (MXWL) (STR) Upgraded; (EPE) (CYS) (TEX) Downgraded
-
Notable 52-Week Highs and Lows 6/11: (C) (LLY) (MW) High; (CHK) (ZQK) (MARA) Low